C
CTKB
Cytek Biosciences, Inc.
4.515
-0.005-0.11%Opening10:29 04/07 EDT
OPEN/PREV CLOSE4.510/4.520
TODAY RANGE4.435-4.635
VOL24
MARKET CAP591.33M
52 WEEK RANGE2.370-6.18
AVG VOL (3M)814.15K
% TURNOVER0.39%
TURNOVER0
P/E (TTM)-8.8309
% RANGE4.42%
EPS(TTM)-0.5209
P/E(FORWARD)-20.4444
P/B1.730
BVPS2.658
DIVIDEND--
P/S2.935
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP541.35M
SHARES OUTSTANDING128.55M
NEXT EARNINGS05/06-05/11
FREE FLOAT117.69M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·03/25 11:05
Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your Watchlist
TipRanks·03/07 00:21
Cytek Biosciences Balances Growth With Margin Strain
Simply Wall St·02/28 01:22
Cytek Biosciences (CTKB) Q4 EPS Swing To Loss Reinforces Margin Concerns
NASDAQ·02/27 14:13
Cytek (CTKB) Q4 2025 Earnings Call Transcript
NASDAQ·02/27 01:05
Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates
Seeking Alpha·02/26 22:24
Cytek Biosciences GAAP EPS of -$0.34 misses by $0.30, revenue of $62.1M beats by $3.3M
Reuters·02/26 21:54
Cytek Biosciences Q4 revenue rises 8%
Benzinga·02/26 21:10
Earnings Breakdown: Cytek Biosciences Q4
Reuters·02/26 21:05
BRIEF-Cytek Biosciences Q4 Pretax Profit USD -4.031 Million
Reuters·02/18 21:06
Cytek Biosciences to Present at TD Cowen 46th Annual Health Care Conference
Simply Wall St·02/13 13:12
Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Share Price Is Still Matching Investor Opinion Despite 27% Slump
Same Industry
Name/Symbol
Change%
Price